Legal & General Group PLC Sarepta Therapeutics, Inc. Transaction History

Legal & General Group PLC

  • $470 Billion
  • Q3 2024

A detailed history of Legal & General Group PLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 152,213 shares of SRPT stock, worth $18.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
152,213
Previous 152,213 -0.0%
Holding current value
$18.4 Million
Previous $19 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$124.33 - $156.75 $571,793 - $720,893
4,599 Added 3.12%
152,213 $19 Million
Q2 2024

Aug 14, 2024
BUY
$113.33 - $163.85 $6.66 Million - $9.62 Million
58,732 Added 66.08%
147,614 $23.3 Million
Q1 2024

Jul 01, 2024
BUY
$93.7 - $141.53 $385,950 - $582,962
4,119 Added 4.86%
88,882 $11.5 Million
Q1 2024

May 14, 2024
SELL
$93.7 - $141.53 $315,019 - $475,823
-3,362 Reduced 3.82%
84,763 $11 Million
Q4 2023

Feb 15, 2024
SELL
$67.31 - $124.76 $297,240 - $550,940
-4,416 Reduced 4.77%
88,125 $8.5 Million
Q3 2023

Nov 14, 2023
BUY
$102.5 - $123.59 $139,810 - $168,576
1,364 Added 1.5%
92,541 $11.2 Million
Q2 2023

Aug 14, 2023
SELL
$106.4 - $157.19 $917,912 - $1.36 Million
-8,627 Reduced 8.64%
91,177 $10.4 Million
Q1 2023

May 15, 2023
BUY
$117.53 - $155.99 $2.2 Million - $2.93 Million
18,757 Added 23.14%
99,804 $13.8 Million
Q4 2022

Feb 14, 2023
BUY
$100.86 - $132.13 $313,977 - $411,320
3,113 Added 3.99%
81,047 $10.5 Million
Q3 2022

Nov 14, 2022
SELL
$75.71 - $119.24 $1.06 Million - $1.67 Million
-14,027 Reduced 15.25%
77,934 $8.62 Million
Q2 2022

Aug 22, 2022
BUY
$62.69 - $88.44 $6,895 - $9,728
110 Added 0.12%
91,961 $6.89 Million
Q1 2022

May 16, 2022
BUY
$63.15 - $90.42 $304,130 - $435,462
4,816 Added 5.53%
91,851 $7.18 Million
Q4 2021

Feb 14, 2022
BUY
$77.28 - $99.42 $66,228 - $85,202
857 Added 0.99%
87,035 $7.84 Million
Q3 2021

Nov 15, 2021
SELL
$65.97 - $92.48 $9.26 Million - $13 Million
-140,315 Reduced 61.95%
86,178 $7.97 Million
Q2 2021

Aug 12, 2021
SELL
$69.38 - $86.75 $13 Million - $16.2 Million
-186,870 Reduced 45.21%
226,493 $17.6 Million
Q1 2021

May 17, 2021
BUY
$72.25 - $168.95 $506,255 - $1.18 Million
7,007 Added 1.72%
413,363 $30.8 Million
Q4 2020

Feb 12, 2021
SELL
$125.56 - $178.74 $285,649 - $406,633
-2,275 Reduced 0.56%
406,356 $69.3 Million
Q3 2020

Nov 13, 2020
BUY
$127.12 - $172.34 $18.6 Million - $25.2 Million
146,219 Added 55.72%
408,631 $57.4 Million
Q2 2020

Aug 14, 2020
BUY
$93.0 - $171.7 $1.05 Million - $1.93 Million
11,264 Added 4.49%
262,412 $42.1 Million
Q1 2020

May 14, 2020
BUY
$82.38 - $131.64 $1.75 Million - $2.8 Million
21,251 Added 9.24%
251,148 $24.6 Million
Q4 2019

Feb 13, 2020
BUY
$76.53 - $135.58 $3.91 Million - $6.92 Million
51,076 Added 28.56%
229,897 $29.7 Million
Q3 2019

Nov 13, 2019
BUY
$72.81 - $156.91 $10.2 Million - $21.9 Million
139,836 Added 358.69%
178,821 $13.5 Million
Q2 2019

Aug 14, 2019
BUY
$112.21 - $151.95 $174,374 - $236,130
1,554 Added 4.15%
38,985 $5.92 Million
Q1 2019

May 15, 2019
BUY
$106.67 - $151.68 $246,834 - $350,987
2,314 Added 6.59%
37,431 $4.46 Million
Q4 2018

Feb 15, 2019
BUY
$97.32 - $148.76 $572,046 - $874,411
5,878 Added 20.1%
35,117 $3.83 Million
Q3 2018

Nov 20, 2018
BUY
$115.31 - $161.51 $123,842 - $173,461
1,074 Added 3.81%
29,239 $4.72 Million
Q2 2018

Aug 10, 2018
BUY
$71.74 - $153.69 $221,317 - $474,133
3,085 Added 12.3%
28,165 $3.72 Million
Q1 2018

May 17, 2018
SELL
$54.02 - $82.27 $69,307 - $105,552
-1,283 Reduced 4.87%
25,080 $1.86 Million
Q4 2017

Feb 13, 2018
BUY
$47.64 - $56.75 $1.26 Million - $1.5 Million
26,363
26,363 $1.47 Million

Others Institutions Holding SRPT

# of Institutions
529
Shares Held
84.2M
Call Options Held
2.06M
Put Options Held
1.52M
View Full List

About Sarepta Therapeutics, Inc.

SRPT Quotes by TradingView
  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.6B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email